{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:15:18Z","timestamp":1790442918893,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.drugalcdep.2008.10.016","type":"journal-article","created":{"date-parts":[[2008,12,6]],"date-time":"2008-12-06T10:25:30Z","timestamp":1228559130000},"page":"34-41","source":"Crossref","is-referenced-by-count":107,"title":["Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"101","author":[{"given":"Marc E.","family":"Mooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V.","family":"Herin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy M.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidal","family":"Moukaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2008.10.016_bib1","unstructured":"American Psychiatric Association, 1994. Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association, Washington, DC."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/02791072.2000.10400221","article-title":"History of the methamphetamine problem","volume":"32","author":"Anglin","year":"2000","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib3","first-page":"301","article-title":"The need for speed: an update on methamphetamine addiction","volume":"31","author":"Barr","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib4","first-page":"599","article-title":"An inventory of measuring depression","volume":"49","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archpsyc.61.3.264","article-title":"Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial","volume":"61","author":"Carroll","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugalcdep.2004.02.007","article-title":"Choosing a behavioral therapy platform for pharmacotherapy of substance users","volume":"75","author":"Carroll","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1360-0443.2007.01798.x","article-title":"A vision of the next generation of behavioral therapies research in the addictions","volume":"102","author":"Carroll","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib8","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s002130100727","article-title":"Effects of repeated oral methamphetamine administration in humans","volume":"155","author":"Comer","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib10","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1530-0277.1996.tb01142.x","article-title":"Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer","volume":"20","author":"Del Boca","year":"1996","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib12","series-title":"Structured Clinical Interview for DSM-VI Axis I Disorders-Patient Edition (SCID-I\/P, Version 2.0)","author":"First","year":"1995"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00001756-199704140-00006","article-title":"Phentermine\/fenfluramine decreases cocaine self-administration in rhesus monkeys","volume":"8","author":"Glowa","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib14","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2165\/00003495-200464140-00004","article-title":"Agents in development for the management of cocaine abuse","volume":"64","author":"Gorelick","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","article-title":"Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials","volume":"29","author":"Grabowski","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004714-199712000-00008","article-title":"Replacement medication for cocaine dependence: methylphenidate","volume":"17","author":"Grabowski","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00571401","article-title":"Progressive-ratio performance maintained by drug infusions: comparison of cocaine, diethylpropion, chlorphentermine, and fenfluramine","volume":"56","author":"Griffiths","year":"1978","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-9236(97)90155-7","article-title":"A randomized double-blind study of carbamazepine in the treatment of cocaine abuse","volume":"62","author":"Halikas","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002130100738","article-title":"Methamphetamine self-administration by humans","volume":"157","author":"Hart","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00213-003-1464-4","article-title":"Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work","volume":"169","author":"Hart","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1176\/ajp.148.9.1218","article-title":"A behavioral approach to achieving initial cocaine abstinence","volume":"148","author":"Higgins","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)39359-6","article-title":"The discriminative stimulus effects of cocaine in pigeons","volume":"267","author":"Johanson","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4065\/81.1.77","article-title":"Methamphetamine abuse: a perfect storm of complications","volume":"81","author":"Lineberry","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0376-8716(95)01198-6","article-title":"A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients","volume":"40","author":"Margolin","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib26","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1592\/phco.23.12.1281.32697","article-title":"Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations","volume":"23","author":"Markowitz","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archpsyc.1994.03950090045007","article-title":"Noradrenergic dysregulation during discontinuation of cocaine use in addicts","volume":"51","author":"McDougle","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The Fifth Edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib29","unstructured":"Micromedex\u00ae Healthcare Series, n.d. Retrieved June 9, 2008, http:\/\/www.thomsonhc.com. Thompson Healthcare, Greenwood Village, CO."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.10.011","article-title":"Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials","volume":"88","author":"Mooney","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.106.107383","article-title":"Monoamine releasers with varying selectivity for dopamine\/norepinephrine versus serotonin release as candidate \u201cagonist\u201d medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys","volume":"320","author":"Negus","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00213-006-0479-z","article-title":"Reinforcing effects of smoked methamphetamine in rhesus monkeys","volume":"188","author":"Newman","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/jcp.0b013e3181515205","article-title":"Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users","volume":"27","author":"Parasrampuria","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00002826-199108000-00007","article-title":"Clinical effects of daily methamphetamine administration","volume":"14","author":"Perez-Reyes","year":"1991","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1037\/0022-006X.70.2.398","article-title":"Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients","volume":"70","author":"Petry","year":"2002","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.2003.00642.x","article-title":"Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?","volume":"99","author":"Petry","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archpsyc.63.2.219","article-title":"Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population","volume":"63","author":"Poling","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib39","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/0022-006X.69.4.643","article-title":"Shaping cocaine abstinence by successive approximation","volume":"69","author":"Preston","year":"2001","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1749-6632.2002.tb04155.x","article-title":"Appetite suppressants as agonist substitution therapies for stimulant dependence","volume":"965","author":"Rothman","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tips.2006.10.006","article-title":"Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction","volume":"27","author":"Rothman","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib42","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1124\/jpet.104.082503","article-title":"Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration","volume":"313","author":"Rothman","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2000.tb05185.x","article-title":"Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction","volume":"914","author":"Rothman","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib44","unstructured":"SAS Institute Inc., 2008. The SAS System for Windows. SAS Institute Inc., Cary, NC."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib45","doi-asserted-by":"crossref","first-page":"PL303","DOI":"10.1016\/S0024-3205(96)00513-9","article-title":"Phentermine+fenfluramine produce cocaine-like discriminative cues","volume":"59","author":"Schechter","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","article-title":"Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform","volume":"94","author":"Schmitz","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4603(00)00098-8","article-title":"Naltrexone and relapse prevention treatment for cocaine-dependent patients","volume":"26","author":"Schmitz","year":"2001","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib48","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1360-0443.2003.00447.x","article-title":"Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence","volume":"98","author":"Shearer","year":"2003","journal-title":"Addiction"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2008.10.016_bib49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1360-0443.2005.00991.x","article-title":"Randomized controlled pilot trial of cabergoline, hydergine and levodopa\/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST)","volume":"100","author":"Shoptaw","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archpsyc.1996.01830050045007","article-title":"Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy","volume":"53","author":"Silverman","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib51","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.clpt.6100508","article-title":"Contingency management: utility in the treatment of drug abuse disorders","volume":"83","author":"Stitzer","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1523\/JNEUROSCI.18-01-00419.1998","article-title":"Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations","volume":"18","author":"Villemagne","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib53","first-page":"235","article-title":"Quantitative urine levels of cocaine and other substances of abuse","volume":"175","author":"Wilkins","year":"1997","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2008.10.016_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/npp.1993.42","article-title":"A placebo-controlled trial of L-dopa\/carbidopa in early cocaine abstinence","volume":"9","author":"Wolfsohn","year":"1993","journal-title":"Neuropsychopharmacology"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871608003797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871608003797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:40:16Z","timestamp":1738780816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871608003797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":54,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0376871608003797"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.10.016","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}